author-photo

Eugènia Pujol

University of Barcelona

12

Papers

113

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Synthesis, Characterization and HPLC Analysis of the (1S,2S,5R)-Diastereomer and the Enantiomer of the Clinical Candidate AR-15512.

2021 Molecules
Show All
- Source
- Cite
- Save
Citations (1)
In Vitro , In Vivo , and Absorption, Distribution, Metabolism, and Excretion Evaluation of SF 5 -Containing N,N’ -Diarylureas as Antischistosomal Agents

2021 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (0)
2-Oxaadamant-1-yl ureas as soluble epoxide hydrolase inhibitors: in vivo evaluation in a murine model of acute pancreatitis

2020 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (6)
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease.

2020 Neurotherapeutics
Show All
- Source
- Cite
- Save
Citations (17)
New Diarylureas as Activators of the Heme-Regulated EIF2α Kinase for the Treatment of Type 2 Diabetes Mellitus

2019
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer\'s Disease

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (2)
Novel Soluble Epoxide Hydrolase Inhibitors Featuring a 2-Oxaadamantane Moiety: Synthesis, in vitro Profiling and in vivo Evaluation in Murine Models of Acute Pancreatitis

2018 The FASEB Journal
Show All
- Source
- Cite
- Save
Citations (0)
Soluble epoxide hydrolase inhibition as a new therapeutic strategy for the treatment of alzheimer's disease.

2018
Show All
- Source
- Cite
- Save
Citations (0)
Pentafluorosulfanyl-containing Triclocarban Analogs with Potent Antimicrobial Activity

2018 Molecules
Show All
- Source
- Cite
- Save
Citations (16)
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease

2017 Molecular metabolism
Show All
- Source
- Cite
- Save
Citations (42)